Dr. Charisse Valenzuela Caina - General Physician

Dr. Charisse Valenzuela Caina - General Physician General Consults and Non-Emergency Cases
Laboratory Requests and Interpretation
Medical Certificate | Prescription Refill

15/05/2026

HANTAVIRUS: What You Need to Know and How to Stay Safe

from the Philippine Society for Microbiology and Infectious Diseases

12/05/2026

Nearly half of American adults have high blood pressure and many don’t know it. Getting your blood pressure checked is the first step to protecting your heart and brain. Use this chart to see where your numbers fall and talk with your health care professional.

12/05/2026
10/04/2026

Here are 3 tips to support your and wellbeing at work.

Remember: Your employers are also responsible for fostering a work culture where you feel safe and supported.

30/03/2026
28/03/2026

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia:

1. Treat dyslipidemia earlier to reduce lifetime exposure to atherogenic lipoproteins; start lifestyle counseling in youth and consider early pharmacotherapy in high-risk individuals (e.g., familial hypercholesterolemia or LDL-C ≥160 mg/dL).

2. Use the PREVENT™ risk equations instead of older models to estimate 10- and 30-year ASCVD risk in adults aged 30–79, applying the CPR approach: Calculate risk, Personalize assessment, and Reclassify if needed (e.g., with CAC).

3.Consider LDL-lowering therapy in primary prevention starting at a 10-year risk of 3–5%, and recommend it more strongly at 5–10%, after clinician–patient discussion.

4.LDL-C and non-HDL-C targets are reintroduced, while maintaining focus on percentage LDL reduction based on ASCVD risk.

5.Apolipoprotein B (ApoB) measurement can help detect residual lipoprotein-related risk, especially in patients with high triglycerides, diabetes, or low LDL-C.

6.Measure Lipoprotein(a) at least once; elevated levels significantly increase ASCVD risk and warrant more intensive LDL-lowering strategies.

7.Coronary artery calcium (CAC) scoring can refine risk assessment and treatment decisions, particularly in men ≥40 and women ≥45 years.

8.LDL-lowering therapy is recommended for adults aged 40–75 with diabetes, CKD stage 3–4, or HIV regardless of LDL-C level.

9.In secondary prevention, stricter targets are recommended: LDL-C

28/03/2026

📈 Top Health Concerns Among Filipinos in 2025

The Philippine Statistics Authority reports the top causes of death in the country for January to September 2025 (Provisional as of 31 January 2026). Leading the list were:

❤️ Ischaemic heart diseases
🔬 Neoplasms
🧠 Cerebrovascular diseases
🌬️ Pneumonia
🩸 Diabetes mellitus

While the numbers reflect ongoing health challenges, they also remind us to take small steps toward better lifestyle choices, regular check-ups, and stronger support for community health.

Stay informed. Stay healthy. 💙

Read more here:
https://psa.gov.ph/content/2025-causes-death-philippines-provisional-31-january-2026



Address

Naic
4110

Website

Alerts

Be the first to know and let us send you an email when Dr. Charisse Valenzuela Caina - General Physician posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share